STAT3 and hepatocellular carcinoma: Thus, activation of p38/MAPK kinases in response to sorafenib-induced stress might contribute to the resistant phenotype in HCC cells by enhancing mitochondrial biogenesis and function through multiple downstream targets, which may include nuclear and mitochondrial STAT3.